Drug Profile
Indeglitazar
Alternative Names: PLX-204; PPM-204Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Plexxikon
- Class Carboxylic acids; Indoles; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor delta agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 27 Jan 2021 Indeglitazar is available for licensing as of 27 Jan 2021. https://www.plexxikon.com/partnering/
- 04 Apr 2011 Plexxikon has been acquired by Daiichi Sankyo Company
- 22 Sep 2010 Indeglitazar is available for licensing (\www.plexxikon.com\)